|
上海医药集团股份有限公司- H股, 02607.HK - 综合损益表 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
2008-12 |
营业额 |
231,981,300 |
215,824,259 |
191,909,156 |
186,565,796 |
159,084,397 |
130,847,179 |
120,764,660 |
105,516,587 |
92,398,894 |
78,222,817 |
68,078,118 |
54,899,873 |
37,381,568 |
31,228,163 |
27,440,761 |
经营溢利 |
9,014,650 |
8,205,486 |
7,184,388 |
6,686,061 |
5,505,082 |
5,321,324 |
3,784,556 |
3,631,160 |
3,063,297 |
2,749,134 |
2,595,421 |
2,379,632 |
1,808,805 |
1,352,393 |
1,003,026 |
非经营/ 特殊项目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
80,260 |
469,772 |
-85,282 |
联营公司 |
0 |
0 |
0 |
765,186 |
647,711 |
551,792 |
953,465 |
616,800 |
413,003 |
399,416 |
338,393 |
303,750 |
283,470 |
307,879 |
287,758 |
除税前经营溢利 |
8,808,353 |
8,143,815 |
7,175,483 |
6,262,467 |
5,343,378 |
5,204,808 |
4,638,996 |
4,171,854 |
3,799,734 |
3,225,640 |
3,087,727 |
3,035,102 |
2,172,535 |
2,130,044 |
1,205,502 |
税项 |
1,816,339 |
1,869,245 |
1,570,219 |
1,431,725 |
887,117 |
1,147,029 |
809,284 |
807,486 |
807,717 |
628,368 |
627,139 |
589,072 |
393,550 |
464,854 |
210,193 |
少数股东权益 |
1,374,863 |
1,181,102 |
1,109,047 |
749,748 |
575,198 |
537,135 |
633,318 |
487,379 |
400,886 |
383,693 |
407,716 |
403,791 |
410,732 |
368,401 |
298,317 |
股东应占溢利 |
5,617,152 |
5,093,467 |
4,496,217 |
4,080,994 |
3,881,063 |
3,520,644 |
3,196,394 |
2,876,989 |
2,591,131 |
2,213,579 |
2,052,872 |
2,042,239 |
1,368,253 |
1,296,789 |
696,992 |
货币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
单位 |
千 |
千 |
千 |
千 |
主要项目 |
折旧 |
2,213,091 |
2,131,516 |
2,119,051 |
2,043,847 |
1,302,205 |
934,366 |
824,044 |
745,829 |
685,418 |
603,621 |
577,862 |
497,263 |
367,150 |
397,092 |
368,324 |
利息 |
1,689,279 |
1,518,228 |
1,411,893 |
1,405,213 |
1,006,064 |
875,743 |
697,484 |
613,271 |
588,328 |
415,226 |
472,381 |
461,796 |
204,944 |
214,228 |
302,489 |
利息拨作发展资本 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3,402 |
1,479 |
0 |
0 |
0 |
0 |
0 |
处置/重估固定资产 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
税率(%) |
20.62 |
22.95 |
21.88 |
22.86 |
16.6 |
22.04 |
17.45 |
19.36 |
21.26 |
19.48 |
20.31 |
19.41 |
18.11 |
21.82 |
17.44 |
营业额增长(%) |
7.49 |
12.46 |
2.86 |
17.27 |
21.58 |
8.35 |
14.45 |
14.2 |
18.12 |
14.9 |
24.0 |
46.86 |
19.7 |
13.8 |
|
股东应占溢利增长(%) |
10.28 |
13.28 |
10.17 |
5.15 |
10.24 |
10.14 |
11.1 |
11.03 |
17.06 |
7.83 |
0.52 |
49.26 |
5.51 |
86.06 |
|
核数师意见 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
说明:1代表无保留意见;2代表保留意见;3代表修改意见
|
|